- Home
- ELAN vs VRNA Comparison
ELAN vs VRNA Comparison
Compare ELAN & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAN
- VRNA
- Stock Information
- Founded
- ELAN 1954
- VRNA 2005
- Country
- ELAN United States
- VRNA United Kingdom
- Employees
- ELAN N/A
- VRNA N/A
- Industry
- ELAN Biotechnology: Pharmaceutical Preparations
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- ELAN Health Care
- VRNA Health Care
- Exchange
- ELAN Nasdaq
- VRNA Nasdaq
- Market Cap
- ELAN 7.2B
- VRNA 8.3B
- IPO Year
- ELAN 2018
- VRNA 2017
- Fundamental
- Price
- ELAN $18.56
- VRNA $105.79
- Analyst Decision
- ELAN Buy
- VRNA Buy
- Analyst Count
- ELAN 7
- VRNA 11
- Target Price
- ELAN $17.33
- VRNA $114.10
- AVG Volume (30 Days)
- ELAN 7.3M
- VRNA 1.4M
- Earning Date
- ELAN 08-07-2025
- VRNA 08-06-2025
- Dividend Yield
- ELAN N/A
- VRNA N/A
- EPS Growth
- ELAN N/A
- VRNA N/A
- EPS
- ELAN 0.88
- VRNA N/A
- Revenue
- ELAN $4,484,000,000.00
- VRNA $221,673,000.00
- Revenue This Year
- ELAN $5.65
- VRNA $896.59
- Revenue Next Year
- ELAN $4.97
- VRNA $77.56
- P/E Ratio
- ELAN $21.06
- VRNA N/A
- Revenue Growth
- ELAN N/A
- VRNA N/A
- 52 Week Low
- ELAN $8.02
- VRNA $24.50
- 52 Week High
- ELAN $18.87
- VRNA $105.89
- Technical
- Relative Strength Index (RSI)
- ELAN 75.67
- VRNA 68.01
- Support Level
- ELAN $17.33
- VRNA $105.23
- Resistance Level
- ELAN $18.87
- VRNA $105.81
- Average True Range (ATR)
- ELAN 0.38
- VRNA 0.25
- MACD
- ELAN 0.06
- VRNA -0.36
- Stochastic Oscillator
- ELAN 82.83
- VRNA 87.88
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.